title: Simultaneous myogenin expression and overall DNA hypomethylation promote in vitro myoblast differentiation.
abstract: Two clones of the L5 myoblast line (M6 and the fusion-defective M12) were examined for the expression of myogenin, one of the regulatory genes involved in the regulation of differentiation to myofibers after treatment with 3-deazaadenosine, a metabolic inhibitor of methyl transfer reactions. Cultures treated with 3-deazaadenosine showed, using Northern blot hybridization, a conspicuous increase in myogenin expression, which in clone M6 correlated to the extent of cell differentiation under fusing conditions but was evident also in growth medium, although the drug was unable to start the myogenic program. We also tested the extent of total DNA methylation to verify whether the activation of the regulatory cascade could be correlated to the decrease of the overall number of 5-methylcytosines present in the genome. The results show that the loss of 5-methylcytosine from newly synthesized DNA, but not from preexisting DNA, is evident in fusing conditions and enhanced by 3-deazaadenosine. It appears that there is a positive correlation between the passive demethylation of newly synthesized DNA, the activation of the myogenin gene by demethylation, and the differentiation of myoblasts. However, in fusing conditions, the defective clone M12, although it is able to express myogenin and its DNA is hypomethylated, fuses only in the presence of 3-deazaadenosine, suggesting some alternative way of induction.
authors.affiliation: Department of Human Biopathology, University of Rome La Sapienza, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Scarpa
authors.forename: M
authors.initials: M
authors.lastname: Lucarelli
authors.forename: F
authors.initials: F
authors.lastname: Palitti
authors.forename: D
authors.initials: D
authors.lastname: Carotti
authors.forename: R
authors.initials: R
authors.lastname: Strom
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D015139:Blotting, Southern; D002454:Cell Differentiation / Q000235:genetics*; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis; D019175:DNA Methylation / Q000187:drug effects*; D006710:Homocysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D018485:Muscle Fibers, Skeletal / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism; D018008:Myogenin / Q000096:biosynthesis* / Q000187:drug effects; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D013234:Stem Cells / Q000378:metabolism; D014372:Tubercidin / Q000494:pharmacology*
chemical_list: C503803:Myog protein, rat; D018008:Myogenin; D012333:RNA, Messenger; C018258:3-deazaadenosine; D006710:Homocysteine; D004247:DNA; C007957:homocysteine thiolactone; D014372:Tubercidin